Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6697)
All Articles published online
|
Nov 28, 2011 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun C, Rosendahl AH, Ansari D, Andersson R. Proteome-based biomarkers in pancreatic cancer. World J Gastroenterol 2011; 17(44): 4845-4852 [PMID: 22171124 DOI: 10.3748/wjg.v17.i44.4845] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i44/4845.htm |
| Number | Citing Articles |
| 1 |
Meritxell Balmaña, Adrià Duran, Catarina Gomes, Esther Llop, Raquel López-Martos, M. Rosa Ortiz, Sílvia Barrabés, Celso A. Reis, Rosa Peracaula. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues. International Journal of Biological Macromolecules 2018; 112: 33 doi: 10.1016/j.ijbiomac.2018.01.148
|
| 2 |
Sheng Pan, Teresa A. Brentnall, Ru Chen. Proteome alterations in pancreatic ductal adenocarcinoma. Cancer Letters 2020; 469: 429 doi: 10.1016/j.canlet.2019.11.020
|
| 3 |
Ulf Landegren, Maria Hammond. Cancer diagnostics based on plasma protein biomarkers: hard times but great expectations. Molecular Oncology 2021; 15(6): 1715 doi: 10.1002/1878-0261.12809
|
| 4 |
Yuanwei Xu, Yuefan Wang, Naseruddin Höti, David J. Clark, Shao‐Yung Chen, Hui Zhang. The next “sweet” spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection. Mass Spectrometry Reviews 2023; 42(2): 822 doi: 10.1002/mas.21748
|
| 5 |
Steven Haenen, Elke Clynen, Benoit Nemery, Peter H.M. Hoet, Jeroen A.J. Vanoirbeek. Biomarker discovery in asthma and COPD: Application of proteomics techniques in human and mice. EuPA Open Proteomics 2014; 4: 101 doi: 10.1016/j.euprot.2014.04.008
|
| 6 |
Hui-Lin Ye, Dou-Dou Li, Qing Lin, Yu Zhou, Quan-Bo Zhou, Bing Zeng, Zhi-Qiang Fu, Wen-Chao Gao, Yi-Min Liu, Rui-Wan Chen, Zhi-Hua Li, Ru-Fu Chen. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival. World Journal of Gastroenterology 2015; 21(21): 6621-6630 doi: 10.3748/wjg.v21.i21.6621
|
| 7 |
Paola Monterroso Diaz, Ashton Leehans, Prashanth Ravishankar, Anna Daily. Multiomic Approaches for Cancer Biomarker Discovery in Liquid Biopsies: Advances and Challenges. Biomarker Insights 2023; 18 doi: 10.1177/11772719231204508
|
| 8 |
Umashankar K. Ballehaninna, Ronald S. Chamberlain. Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9. Tumor Biology 2013; 34(6): 3279 doi: 10.1007/s13277-013-1033-3
|
| 9 |
Claire Jenkinson, Julie Earl, Paula Ghaneh, Christopher Halloran, Alfredo Carrato, William Greenhalf, John Neoptolemos, Eithne Costello. Biomarkers for early diagnosis of pancreatic cancer. Expert Review of Gastroenterology & Hepatology 2015; 9(3): 305 doi: 10.1586/17474124.2015.965145
|
| 10 |
一 张. Advances in Circulating Biomarkers of Pancreatic Cancer. Advances in Clinical Medicine 2021; 11(05): 2055 doi: 10.12677/ACM.2021.115294
|
| 11 |
Ruchika Bhawal, Ann L. Oberg, Sheng Zhang, Manish Kohli. Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in Cancer. Cancers 2020; 12(9): 2428 doi: 10.3390/cancers12092428
|
| 12 |
Christina Loosse, Katrin Marcus, Bodo Schoenebeck. The Cytoskeleton. Neuromethods 2013; 79: 85 doi: 10.1007/978-1-62703-266-7_5
|
| 13 |
Célia Cintas, Thibaut Douché, Nicole Therville, Silvia Arcucci, Fernanda Ramos-Delgado, Céline Basset, Benoît Thibault, Julie Guillermet-Guibert. Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics. Cancers 2018; 10(6): 174 doi: 10.3390/cancers10060174
|
| 14 |
John A. Williams. Proteomics as a Systems Approach to Pancreatitis. Pancreas 2013; 42(6): 905 doi: 10.1097/MPA.0b013e31828fddc3
|
| 15 |
R Roy, D Zurakowski, J Wischhusen, C Frauenhoffer, S Hooshmand, M Kulke, M A Moses. Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies. British Journal of Cancer 2014; 111(9): 1772 doi: 10.1038/bjc.2014.462
|
| 16 |
Sheng Pan, Teresa A. Brentnall, Kimberly Kelly, Ru Chen. Tissue proteomics in pancreatic cancer study: Discovery, emerging technologies, and challenges. PROTEOMICS 2013; 13(3-4): 710 doi: 10.1002/pmic.201200319
|
| 17 |
Kaisheng Liu, Minshan Lai, Shaoxiang Wang, Kai Zheng, Shouxia Xie, Xiao Wang. Construction of a CXC Chemokine-Based Prediction Model for the Prognosis of Colon Cancer. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/6107865
|
| 18 |
Sheng Pan, Teresa A. Brentnall, Ru Chen. Proteomics analysis of bodily fluids in pancreatic cancer. PROTEOMICS 2015; 15(15): 2705 doi: 10.1002/pmic.201400476
|
| 19 |
Nalin C. W. Goonesekere, Xiaosheng Wang, Lindsey Ludwig, Chittibabu Guda, Jörg D. Hoheisel. A Meta Analysis of Pancreatic Microarray Datasets Yields New Targets as Cancer Genes and Biomarkers. PLoS ONE 2014; 9(4): e93046 doi: 10.1371/journal.pone.0093046
|
| 20 |
Tania Angeles-Floriano, Guadalupe Rivera-Torruco, Paulina García-Maldonado, Esmeralda Juárez, Yolanda Gonzalez, Israel Parra-Ortega, Armando Vilchis-Ordoñez, Briceida Lopez-Martinez, Lourdes Arriaga-Pizano, Dario Orozco-Ruíz, José Refugio Torres-Nava, Paula Licona-Limón, Francisco López-Sosa, Alhelí Bremer, Lourdes Alvarez-Arellano, Ricardo Valle-Rios. Cell surface expression of GRP78 and CXCR4 is associated with childhood high-risk acute lymphoblastic leukemia at diagnostics. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-05857-w
|
| 21 |
Sheng Pan, Teresa A Brentnall, Ru Chen. Glycoproteins and glycoproteomics in pancreatic cancer. World Journal of Gastroenterology 2016; 22(42): 9288-9299 doi: 10.3748/wjg.v22.i42.9288
|
| 22 |
Dingyuan Hu, Daniel Ansari, Krzysztof Pawłowski, Qimin Zhou, Agata Sasor, Charlotte Welinder, Theresa Kristl, Monika Bauden, Melinda Rezeli, Yi Jiang, György Marko-Varga, Roland Andersson. Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma. Oncotarget 2018; 9(11): 9789 doi: 10.18632/oncotarget.23929
|
| 23 |
Danian Tong, Yujia Zhou, Wei Chen, Yang Deng, Lei Li, Zhenyi Jia, Dachuan Qi. T cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and susceptibility to pancreatic cancer. Molecular Biology Reports 2012; 39(11): 9941 doi: 10.1007/s11033-012-1862-y
|
| 24 |
Takeo Kawahara, Naoe Hotta, Yukiko Ozawa, Seiichi Kato, Keiko Kano, Yukihiro Yokoyama, Masato Nagino, Takashi Takahashi, Kiyoshi Yanagisawa, Martin Fernandez-Zapico. Quantitative Proteomic Profiling Identifies DPYSL3 as Pancreatic Ductal Adenocarcinoma-Associated Molecule That Regulates Cell Adhesion and Migration by Stabilization of Focal Adhesion Complex. PLoS ONE 2013; 8(12): e79654 doi: 10.1371/journal.pone.0079654
|
| 25 |
Ai-hua Zhang, Hui Sun, Guang-li Yan, Ying Han, Xi-jun Wang. Serum Proteomics in Biomedical Research: A Systematic Review. Applied Biochemistry and Biotechnology 2013; 170(4): 774 doi: 10.1007/s12010-013-0238-7
|
| 26 |
Katelyn F. Flick, Michele T. Yip-Schneider, Christopher M. Sublette, Rachel E. Simpson, Cameron L. Colgate, Huangbing Wu, Mazhar Soufi, John M. Dewitt, Amber L. Mosley, Eugene P. Ceppa, Jianjun Zhang, C. Max Schmidt. A Quantitative Global Proteomics Approach Identifies Candidate Urinary Biomarkers That Correlate With Intraductal Papillary Mucinous Neoplasm Dysplasia. Pancreas 2020; 49(8): 1044 doi: 10.1097/MPA.0000000000001628
|
| 27 |
Lucie Habartová, Bohuš Bunganič, Michal Tatarkovič, Miroslav Zavoral, Jana Vondroušová, Kamila Syslová, Vladimír Setnička. Chiroptical spectroscopy and metabolomics for blood‐based sensing of pancreatic cancer. Chirality 2018; 30(5): 581 doi: 10.1002/chir.22834
|
| 28 |
Cristina Jimenez-Luna, Carolina Torres, Raul Ortiz, Carmelo Dieguez, Joaquina Martinez-Galan, Consolacion Melguizo, Jose C. Prados, Octavio Caba. Proteomic biomarkers in body fluids associated with pancreatic cancer. Oncotarget 2018; 9(23): 16573 doi: 10.18632/oncotarget.24654
|
| 29 |
Krissi Danielsson, Daniel Ansari, Roland Andersson. Personalizing Pancreatic Cancer Medicine: What are the Challenges?. Personalized Medicine 2013; 10(1): 45 doi: 10.2217/pme.12.111
|